This article was first published by The Times of Israel and is re-posted with permission.
New Israeli research may pave the way for drugs that “turn off the hunger switch” in the human brain with minimal side effects, scientists say.
A receptor in the brain, melanocortin 4 (MC4), is known to control the urge to eat. It has been dubbed the “hunger switch.”
A genetically inherited malfunction with this receptor is believed to be the most common cause of obesity that is triggered by a single gene mutation, impacting an estimated 5 percent of early-onset childhood obesity.
To read the full article, click here.
SEE ALSO: Tel Aviv Named 6th Healthiest City In The World – Report
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Growing Bone From Your Own Tissue For ‘Seamless’ Healing
April 25, 2024
Femtech Firm Aims To Cure Endometriosis With Cannabinoids
April 07, 2024
Facebook comments